Pacific Edge Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PEB.NZ | MDXH | BDSX | BNR | IMDX | MYGN | |
|---|---|---|---|---|---|---|
| Market cap | 285.63M | 17.49M | 223.47M | 124.66M | 92.61M | 556.68M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -19.1 | -0.5 | -96.3 | -20.4 | -3.5 | -9.9 |
| Price/book | 23.0 | -0.3 | 24.4 | 1.7 | -4.3 | 1.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +26.34% | −95.86% | +255.72% | +1.49% | −57.16% | −29.33% |
| Today | −2.13% | −0.38% | −11.53% | −10.79% | −0.35% | +1.04% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.
Latest news
All PEB.NZ news ›Pacific Edge Advances US Recovery with Medicare Pricing Boost and Insurer Contracts
Pacific Edge secures new US insurer contracts as proposed Medicare rates rise up to 39%, advancing its bladder cancer testing recovery. Pacific Edge (ASX: PEB) has secured new US insurer contracts and flagged substantial proposed Medicare…
Pacific Edge Limited: Relative Strength Chart - Stock New Zealand S.E.
Compare Pacific Edge Limited with the company of your choice via a Relative Strength chart. Real-time PEB price, New Zealand S.E. stock exchange Relative Strength Chart Pacific Edge Limited Biotechnology & Medical Research All financial…
Transcript : Pacific Edge Limited, 2026 Earnings Call, May 11, 2026
Presenter SpeechPeter Meintjes Good morning, everybody. Welcome to the investor briefing associated with our capital raising presentation. I'm Dr. Peter Meintjes, Chief Executive of Pacific Edge. Transcript : Pacific Edge Limited, 2026…
Pacific Edge Signals US Recovery Momentum as Proposed Medicare Rates Rise
marketscreener.com Biotechnology & Medical Research Pacific Edge Signals US Recovery Momentum as Proposed Medicare Rates Rise Published on 10/18/2026 at 05:56 pm EDT
Pacific Edge's APAC Business Progresses Toward Profitability on Higher Commercial Test Volumes
Pacific Edge said its Asia-Pacific operations are progressing toward profitability on a direct-cost basis, supported by higher commercial test volumes and gaining adoption of the Cxbladder Triage... Biotechnology & Medical Research Pacific…
Pacific Edge Limited: Total Return chart (Dividends reinvested) - New Zealand S.E. stock market
See the history of Pacific Edge Limited, with dividends reinvested. (Total Return chart) PEB Stock market Total Return chart Pacific Edge Limited Biotechnology & Medical Research All financial news and data tailored to specific country…
Pacific Edge Announces Appointment of Willy Iglesias as Chief Digital Officer, Effective August 25, 2026
Pacific Edge announced the appointment of Willy Iglesias as Chief Digital Officer, effective August 25, 2026. Mr. Iglesias brought to Pacific Edge deep experience leading digital transformation in... Pacific Edge announced the appointment…
Pacific Edge Adopting More Focused Strategy to Reverse US Commercial Test Volume Decline, Jarden Says
Pacific Edge is pursuing what appears to be a more focused strategy to reverse a decline in US commercial test volumes, with a clear focus on intermediate-risk microhematuria patients, Jarden said... Biotechnology & Medical Research…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com7
-
proactiveinvestors.com1
-
smallcaps.com.au1
-
theglobeandmail.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.